[go: up one dir, main page]

DK1299354T3 - Faktor VIIA hæmmende (thio)urea-derivater, fremstilling og anvendelse deraf - Google Patents

Faktor VIIA hæmmende (thio)urea-derivater, fremstilling og anvendelse deraf

Info

Publication number
DK1299354T3
DK1299354T3 DK01955291T DK01955291T DK1299354T3 DK 1299354 T3 DK1299354 T3 DK 1299354T3 DK 01955291 T DK01955291 T DK 01955291T DK 01955291 T DK01955291 T DK 01955291T DK 1299354 T3 DK1299354 T3 DK 1299354T3
Authority
DK
Denmark
Prior art keywords
thio
preparation
factor viia
urea derivatives
viia inhibitory
Prior art date
Application number
DK01955291T
Other languages
English (en)
Inventor
Otmar Klingler
Manfred Schudok
Hans-Peter Nestler
Hans Matter
Herman Schreuder
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1299354T3 publication Critical patent/DK1299354T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK01955291T 2000-06-06 2001-05-26 Faktor VIIA hæmmende (thio)urea-derivater, fremstilling og anvendelse deraf DK1299354T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00112116A EP1162194A1 (en) 2000-06-06 2000-06-06 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use
PCT/EP2001/006029 WO2001094301A2 (en) 2000-06-06 2001-05-26 Factor viia inhibitory (thio)urea derivatives, their preparation and their use

Publications (1)

Publication Number Publication Date
DK1299354T3 true DK1299354T3 (da) 2009-11-16

Family

ID=8168926

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01955291T DK1299354T3 (da) 2000-06-06 2001-05-26 Faktor VIIA hæmmende (thio)urea-derivater, fremstilling og anvendelse deraf

Country Status (30)

Country Link
US (1) US6743790B2 (da)
EP (2) EP1162194A1 (da)
JP (1) JP4809570B2 (da)
KR (1) KR101011345B1 (da)
CN (1) CN1208314C (da)
AR (1) AR030936A1 (da)
AU (2) AU7749401A (da)
BR (1) BR0111264A (da)
CA (1) CA2410862C (da)
CZ (1) CZ20023963A3 (da)
DE (1) DE60139320D1 (da)
DK (1) DK1299354T3 (da)
EE (1) EE200200617A (da)
ES (1) ES2330412T3 (da)
HK (1) HK1055941A1 (da)
HR (1) HRP20020961A2 (da)
HU (1) HUP0301631A2 (da)
IL (2) IL153220A0 (da)
MX (1) MXPA02009789A (da)
MY (1) MY129363A (da)
NO (1) NO328546B1 (da)
NZ (1) NZ522960A (da)
PL (1) PL359584A1 (da)
PT (1) PT1299354E (da)
RU (1) RU2286337C2 (da)
SK (1) SK17032002A3 (da)
TW (1) TWI283662B (da)
WO (1) WO2001094301A2 (da)
YU (1) YU89202A (da)
ZA (1) ZA200209018B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1499591A1 (de) * 2002-04-27 2005-01-26 MERCK PATENT GmbH Carbonsäureamide als inhibitoren des koagulationsfaktors xa
PL374971A1 (en) * 2002-08-09 2005-11-14 Transtech Pharma, Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
CA2525854C (en) * 2003-05-20 2009-12-15 Genentech, Inc. Acylsulfamide inhibitors of factor viia
WO2004113316A1 (en) * 2003-05-20 2004-12-29 Genentech, Inc. Benzofuran inhibitors of factor viia
WO2005014532A1 (en) * 2003-08-08 2005-02-17 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions and methods of use
US7208601B2 (en) * 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
JP2007501844A (ja) * 2003-08-08 2007-02-01 トランス　テック　ファーマ，インコーポレイテッド アリール及びヘテロアリール化合物、組成物並びに使用方法
WO2006041119A1 (ja) * 2004-10-13 2006-04-20 Eisai R & D Management Co., Ltd. ヒドラジド誘導体
TW200630337A (en) * 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
EP1855722A2 (en) * 2005-02-24 2007-11-21 Novo Nordisk Health Care AG Compounds for stabilizing factor vii polypeptide formulations
EP1856037A1 (en) * 2005-02-24 2007-11-21 Novo Nordisk Health Care AG Amidino-compounds for stabilizing factor vii polypeptide formulations
US20080312161A1 (en) * 2005-02-24 2008-12-18 Anders Klarskov Petersen Compounds For Stabilizing Factor VII Polypeptide Formulations
WO2006134173A2 (en) 2005-06-17 2006-12-21 Novo Nordisk Health Care Ag Selective reduction and derivatization of engineered proteins comprising at least one non-native cysteine
EP2000465B1 (en) 2006-03-24 2010-12-15 Eisai R&D Management Co., Ltd. Triazolone derivative
WO2007110449A1 (en) * 2006-03-29 2007-10-04 Euro-Celtique S.A. Benzenesulfonamide compounds and their use
WO2007118853A1 (en) * 2006-04-13 2007-10-25 Euro-Celtique S.A. Benzenesulfonamide compounds and their use as blockers of calcium channels
US8937181B2 (en) * 2006-04-13 2015-01-20 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
US8399486B2 (en) * 2007-04-09 2013-03-19 Purdue Pharma L.P. Benzenesulfonyl compounds and the use thereof
JPWO2009038157A1 (ja) * 2007-09-21 2011-01-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 ２，３−ジヒドロ−イミノイソインドール誘導体
WO2009040659A2 (en) * 2007-09-28 2009-04-02 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
ES2708997T3 (es) 2011-10-26 2019-04-12 Allergan Inc Derivados de amida de aminoácidos N-Urea sustituidos como moduladores del receptor análogo al receptor 1 de péptido formilado (FPRL-1)
US9670150B2 (en) 2012-04-16 2017-06-06 Allergan, Inc. (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators
CN104717973A (zh) * 2012-10-10 2015-06-17 诺和诺德保健Ag（股份有限公司） 因子vii多肽的液体药物组合物
RU2696487C2 (ru) 2013-03-06 2019-08-02 Аллерган, Инк. Применение агонистов формилпептидного рецептора 2 для лечения дерматологических заболеваний
BR112015021371B1 (pt) 2013-03-06 2021-04-13 Allergan, Inc Uso de agonistas de receptor de formil peptídeo 2 para tratar doenças inflamatórias oculares

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273982A (en) * 1990-03-09 1993-12-28 Hoffmann-La Roche Inc. Acetic acid derivatives
US5506134A (en) 1990-10-22 1996-04-09 Corvas International, Inc. Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
EP0570507A4 (en) * 1991-02-05 1994-09-21 Smithkline Beecham Corp Anti-aggregatory peptides containing an aromatic ester or amide
US5833982A (en) 1991-02-28 1998-11-10 Zymogenetics, Inc. Modified factor VII
US5788965A (en) 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
JP3387948B2 (ja) * 1992-12-04 2003-03-17 富山化学工業株式会社 新規なフェニルアラニン誘導体またはその塩
US5314902A (en) 1993-01-27 1994-05-24 Monsanto Company Urea derivatives useful as platelet aggregation inhibitors
DE4309867A1 (de) 1993-03-26 1994-09-29 Cassella Ag Neue Harnstoffderivate, ihre Herstellung und Verwendung
GB9313269D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Allophanic acid derivatives
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
WO1995008550A1 (en) * 1993-09-24 1995-03-30 Abbott Laboratories Endothelin antagonists
EP0725059B1 (en) * 1993-10-19 2001-01-17 Sumitomo Pharmaceuticals Company, Limited 2,3-diaminopropionic acid derivative
US5674894A (en) * 1995-05-15 1997-10-07 G.D. Searle & Co. Amidine derivatives useful as platelet aggregation inhibitors and vasodilators
CA2243507A1 (en) * 1996-01-30 1997-08-07 Christopher J. Dinsmore Inhibitors of farnesyl-protein transferase
JP3786578B2 (ja) * 1997-11-18 2006-06-14 帝人ファーマ株式会社 環状アミン誘導体、およびその薬剤としての使用法
EP0987274A1 (en) * 1998-09-15 2000-03-22 Hoechst Marion Roussel Deutschland GmbH Factor VIIa Inhibitors

Also Published As

Publication number Publication date
KR101011345B1 (ko) 2011-01-28
ES2330412T3 (es) 2009-12-10
AR030936A1 (es) 2003-09-03
EP1299354A2 (en) 2003-04-09
TWI283662B (en) 2007-07-11
CZ20023963A3 (cs) 2003-03-12
HUP0301631A2 (hu) 2003-09-29
SK17032002A3 (sk) 2003-05-02
MXPA02009789A (es) 2003-03-12
NO20025810L (no) 2002-12-03
NO328546B1 (no) 2010-03-15
NO20025810D0 (no) 2002-12-03
BR0111264A (pt) 2003-06-17
EE200200617A (et) 2004-04-15
AU7749401A (en) 2001-12-17
MY129363A (en) 2007-03-30
JP2003535844A (ja) 2003-12-02
KR20030007911A (ko) 2003-01-23
NZ522960A (en) 2004-05-28
DE60139320D1 (de) 2009-09-03
CN1427818A (zh) 2003-07-02
JP4809570B2 (ja) 2011-11-09
WO2001094301A3 (en) 2002-04-04
IL153220A0 (en) 2003-07-06
CA2410862C (en) 2009-11-10
RU2286337C2 (ru) 2006-10-27
IL153220A (en) 2008-11-03
HK1055941A1 (en) 2004-01-30
ZA200209018B (en) 2003-10-08
PT1299354E (pt) 2009-10-01
HRP20020961A2 (en) 2004-12-31
AU2001277494B2 (en) 2006-05-04
EP1299354B1 (en) 2009-07-22
US6743790B2 (en) 2004-06-01
CN1208314C (zh) 2005-06-29
YU89202A (sh) 2006-05-25
EP1162194A1 (en) 2001-12-12
CA2410862A1 (en) 2001-12-13
PL359584A1 (en) 2004-08-23
US20020052417A1 (en) 2002-05-02
WO2001094301A2 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
DK1299354T3 (da) Faktor VIIA hæmmende (thio)urea-derivater, fremstilling og anvendelse deraf
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
EE201300011A (et) Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina
DK1165516T3 (da) Heterocyklisk urinstof og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler
HUP0401335A3 (en) Herbicidal pyridylpropynyloxyphenyl derivatives, preparation and use thereof
NO20042635L (no) 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
DK1250328T3 (da) Dihydro-1,3,5-triazin-aminderivater og terapeutisk anvendelse deraf
NO20014603L (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
EE200300327A (et) Uurea derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutiline kompositsioon
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
ATE303388T1 (de) Substituierte 2-pyridinyl-6,7,8,9- tetrahydropyrimidoc1,2-aöpyrimidin-4-on- und 7- pyridinyl-2,3-dihydroimidazo-c1,2-aöpyrimidin- 5(1h)onderivate
IS6420A (is) Setnar Fenýl-píperazín afleiður, framleiðsla þeirra og notkun
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
DK1202996T3 (da) Titanforbindelser, fremstilling og anvendelse heraf
DK1345900T3 (da) Guanidin- og amidinderivater som faktor XA-inhibitorer
ZA200309513B (en) Novel heterocyclic derivatives and medicinal use thereof.
DK1343764T3 (da) Urinstof og urethanderivater som integrininhibitorer
IL157043A0 (en) Aryl carbamate derivatives, preparation and use thereof